Clinical Trials
5 trialsNCT06984159 2025-05-22
The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03936218 2025-04-17
Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer
Eurofarma Laboratorios S.A.
Phase 3 Completed
NCT02234089 2019-07-05
ProComD
Ferring Pharmaceuticals
Completed
NCT01383863 2019-01-14
TRIPTOCARE LT
Ipsen
Completed
NCT00871585 2010-04-15
Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide
AstraZeneca
Completed